Primary |
Product Used For Unknown Indication |
46.5% |
Respiratory Tract Congestion |
6.2% |
Blood Pressure |
4.7% |
Sinus Congestion |
4.7% |
Nasopharyngitis |
3.9% |
Nasal Congestion |
3.1% |
Nausea |
3.1% |
Pain |
3.1% |
Sinus Disorder |
3.1% |
Sinusitis |
3.1% |
Blood Cholesterol |
2.3% |
Cough |
2.3% |
Feeling Abnormal |
2.3% |
Multiple Allergies |
2.3% |
Asthma |
1.6% |
Chronic Obstructive Pulmonary Disease |
1.6% |
Glaucoma |
1.6% |
Irritable Bowel Syndrome |
1.6% |
Otorrhoea |
1.6% |
Rhinorrhoea |
1.6% |
|
Incorrect Drug Administration Duration |
12.8% |
Epistaxis |
9.0% |
Hallucination |
7.7% |
Tremor |
7.7% |
Wrong Technique In Drug Usage Process |
7.7% |
Vomiting |
6.4% |
Blood Pressure Increased |
5.1% |
Haemoptysis |
3.8% |
Heart Rate Increased |
3.8% |
Hypertension |
3.8% |
Psychomotor Hyperactivity |
3.8% |
Restlessness |
3.8% |
Swelling Face |
3.8% |
Tachycardia |
3.8% |
Ventricular Tachycardia |
3.8% |
Anuria |
2.6% |
Arrhythmia |
2.6% |
Asthenia |
2.6% |
Atrial Fibrillation |
2.6% |
Dysuria |
2.6% |
|
Secondary |
Product Used For Unknown Indication |
50.0% |
Respiratory Tract Congestion |
8.3% |
Feeling Abnormal |
5.6% |
Sinusitis |
5.6% |
Cough |
2.8% |
Headache |
2.8% |
Heart Rate Irregular |
2.8% |
Nasal Congestion |
2.8% |
Respiratory Tract Infection |
2.8% |
Upper Respiratory Tract Infection |
2.8% |
Asthma |
1.4% |
Hypertonic Bladder |
1.4% |
Increased Upper Airway Secretion |
1.4% |
Labyrinthitis |
1.4% |
Lower Respiratory Tract Infection |
1.4% |
Multiple Allergies |
1.4% |
Nasal Inflammation |
1.4% |
Nasopharyngitis |
1.4% |
Sinus Disorder |
1.4% |
Upper Respiratory Tract Congestion |
1.4% |
|
Wrong Technique In Drug Usage Process |
16.7% |
Rash |
11.1% |
Incorrect Drug Administration Duration |
8.3% |
Insomnia |
8.3% |
Drug Hypersensitivity |
5.6% |
Restless Legs Syndrome |
5.6% |
Urinary Retention |
5.6% |
Urinary Tract Disorder |
5.6% |
Diarrhoea |
2.8% |
Epistaxis |
2.8% |
Haematochezia |
2.8% |
Hallucination |
2.8% |
Heart Rate Increased |
2.8% |
Hernia |
2.8% |
Inappropriate Schedule Of Drug Administration |
2.8% |
Injection Site Haemorrhage |
2.8% |
Lip Dry |
2.8% |
Loss Of Consciousness |
2.8% |
Mania |
2.8% |
Medication Error |
2.8% |
|
Concomitant |
Product Used For Unknown Indication |
33.1% |
Drug Use For Unknown Indication |
14.1% |
Asthma |
4.7% |
Cough |
4.2% |
Hypersensitivity |
4.2% |
Pain |
3.9% |
Mycobacterium Avium Complex Infection |
3.6% |
Essential Hypertension |
3.1% |
Diabetes Mellitus |
2.9% |
Multiple Sclerosis |
2.9% |
Pneumonia |
2.9% |
Respiratory Tract Congestion |
2.9% |
Nasal Congestion |
2.6% |
Urinary Tract Infection |
2.6% |
Hypertension |
2.3% |
Bipolar Disorder |
2.1% |
Rheumatoid Arthritis |
2.1% |
Schizophrenia |
2.1% |
Vitamin Supplementation |
2.1% |
Depression |
1.8% |
|
Drug Ineffective |
10.0% |
Weight Decreased |
8.0% |
Dyspnoea |
6.0% |
Herpes Zoster |
6.0% |
Pulmonary Embolism |
6.0% |
Sinusitis |
6.0% |
Vomiting |
6.0% |
Cervical Dysplasia |
4.0% |
Colonic Polyp |
4.0% |
Death |
4.0% |
Deep Vein Thrombosis |
4.0% |
Drug Hypersensitivity |
4.0% |
Haematochezia |
4.0% |
Hernia |
4.0% |
Paraesthesia |
4.0% |
Pneumonia Streptococcal |
4.0% |
Pyrexia |
4.0% |
Rash |
4.0% |
Rash Pruritic |
4.0% |
Restlessness |
4.0% |
|